Inovio Sinks While Street Complains of Lack of Vaccine Details

(Bloomberg) -- Inovio Pharmaceuticals Inc. sank as much as 18% on Tuesday after a first look at an experimental vaccine for Covid-19 left investors and analysts clamoring for more details.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.